Welcome and introduction (ID 5997)
State of the art: What are the most current data and updates to treatment guidelines for first-line maintenance in ovarian cancer (ID 5998)
The art of treatment selection: Importance and impact of early treatment planning (ID 5999)
Articles of individualised treatment: How can we begin to individualise treatment using biomarkers and available therapies (ID 6000)
Closing remarks (ID 6001)
